ArticleClinical, cosmetic and investigational dermatology2025
High-Intensity Focused Ultrasound (HIFU) Treatment of Vulvar Lichen Sclerosus.
Article in Clinical, cosmetic and investigational dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- 20-MHz high-intensity focused ultrasound for seborrheic keratoses of the head and neck: outcomes and dermoscopic predictors.Postepy dermatologii i alergologii · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Vulvar lichen sclerosus (VLS) is a chronic, recurrent dermatosis predominantly affecting postmenopausal women. It is characterized by atrophic and sclerotic changes in the vulvar skin, often causing severe discomfort and functional impairment. Although potent topical corticosteroids remain the primary treatment, high-intensity focused ultrasound (HIFU) emerges as a promising alternative in recurrence cases. This study reports the case of a 73-year-old woman with VLS treated using HIFU, aiming to assess the safety and efficacy of this novel therapeutic approach. The patient presented with significant discomfort due to VLS and had a history of limited response to previous treatments. HIFU therapy was applied using the System ONE-M device operating at 20 MHz, targeting specific lesions. The dermoscopic evaluation was performed pre- and post-treatment to assess the treatment response. Immediate post-procedural whitening of tissues was observed, followed by gradual healing over five months. The patient experienced significant symptom relief, including reduced pain and itching, with minimal adverse effects. The treated areas displayed nearly normal skin color, texture, and improved function within five months post-treatment. This case illustrates the potential of HIFU as an effective and precise non-invasive treatment for VLS, offering significant symptom relief while sparing healthy tissue. Further research is needed to refine treatment parameters and explore the broader clinical applicability of HIFU for VLS management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.